Results 1 to 10 of about 472,072 (313)

Some blood parameters in dairy cows with fatty liver syndrome [PDF]

Eurasian Journal of Veterinary Sciences
In this study, a total of 23 dairy cows were used. Blood and liver biopsy samples were obtained from eoxh animal before and after calving. Plasma total lipid, the percentages of different leucocyte types and fatty infiltration of the liver were estimated
Some blood parameters in dairy cows with fatty liver syndrome
doaj   +1 more source

Non-invasive tests for MetALD and alcohol-related liver diseaseKeypoints

JHEP Reports
Summary: Metabolic- and alcohol-related liver disease (MetALD) and alcohol-related liver disease (ALD) are major drivers of the global burden of cirrhosis. While metabolic dysfunction-associated steatotic liver disease (MASLD) affects nearly one-third of
Stine Johansen, Maja Thiele, Aleksander Krag   +2 more
doaj   +1 more source

Evaluating large language models' performance in answering common questions on drug-induced liver injury

JHEP Reports
Background & Aims: Drug-induced liver injury (DILI) is a complex condition often linked to medication behaviors, with patient education having a crucial role in optimizing outcomes.
Yinuo Dong, Zili Zhang, Yang Zhi, Xiaoyun Li, Tengyu Guo, Lanlan He, Shuran Zhao, Xueli Yang, Jieting Tang, Wei Zhong, Qinghui Niu, Mingyang Ma, Zuxiong Huang, Yimin Mao   +13 more
doaj   +1 more source

Association between eGDR and MASLD and liver fibrosis: a cross-sectional study based on NHANES 2017–2023

Frontiers in Medicine
BackgroundThis study aimed to investigate the association between estimated glucose disposal rate (eGDR) and metabolic dysfunction-associated steatotic liver disease (MASLD), as well as liver fibrosis, using data from the National Health and Nutrition ...
Wenjing Peng, Zeyu Li, Nian Fu
doaj   +1 more source

Minimally Invasive, Echocardiography‐Guided Mouse Model of Degenerative Mitral Regurgitation Recapitulates Cardiac Remodeling and Arrhythmogenesis

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Degenerative mitral regurgitation (MR) is a progressive valvular disorder that causes atrial enlargement, cardiac remodeling, heart failure, and arrhythmias.
Wei‐Ting Chang, Nan‐Chun Wu, Chin‐Yu Chen, Zhih‐Cherng Chen, Wei‐Jan Chen, Jhih‐Yuan Shih   +5 more
doaj   +1 more source

Diabetes and Fatty Liver [PDF]

Experimental and Clinical Endocrinology & Diabetes, 2019
Stefan, N., Roden, M.
openaire   +10 more sources

Global assessment of hepatic safety in novel immunotherapies: a systematic review and meta-analysis

Frontiers in Immunology
BackgroundThis study explored whether integrating innovative immunotherapies targeting costimulatory or co-inhibitory pathways beyond standard PD-1, PD-L1, and CTLA-4 treatments affects hepatic adverse events.
Minyan Ye, Yinuo Dong, Xiaoyun Li, Xiaoyun Li, Yang Zhi, Yuping Lu, Jieting Tang, Wei Zhong, Xiaohong Lei, Yimin Mao, Sha Huang, Yanyan Song   +11 more
doaj   +1 more source

Fatty liver and drugs.

European review for medical and pharmacological sciences, 2005
Drug-induced liver diseases (DILD) are clinico-pathologic patterns of liver injury caused by drugs or other foreign compounds. Steatohepatitis is a rare form of DILD, and drugs account for fewer than 2% of non-alcoholic steatohepatitis (NASH). Drugs known to be capable of inducing steatosis and steatohepatitis can be divided into three broad groups ...
Grieco, Antonio, Forgione, Alessandra, Miele, Luca, Vero, Vittoria, Greco, Av, Gasbarrini, Antonio, Gasbarrini, Giovanni Battista   +6 more
openaire   +2 more sources

The Tumor-Associated Neutrophils-Related Signatures Predict Prognosis and Indicate Immune Landscape in Colorectal Carcinoma

Mediators of Inflammation
Conclusions: This study comprehensively analyzed the role of TANs in CRC progression and developed a prognostic model based on TANs-related genes, which holds significant potential for predicting prognosis and immunotherapy outcomes in CRC patients.
Ying Wang, Yizhen Zhu, Yuling Zeng, Shuhui Gao, Youcai Tang, Ming Wei   +5 more
doaj   +1 more source

Ability of soluble TREM2 and PRO-C3 as biomarkers to predict changes in MASLD activity

JHEP Reports
Background & Aims: Diet and weight loss remain the primary treatment for most patients with metabolic dysfunction-associated fatty liver disease (MASLD), with one recent drug therapy approved for severe cases.
Charlotte Wilhelmina Wernberg, Vineesh Indira Chandran, Mette Munk Lauridsen, Maria Kløjgaard Skytthe, Camilla Dalby Hansen, Johanne Kragh Hansen, Lea Ladegaard Grønkjær, Birgitte Gade Jacobsen, Tina Di Caterino, Sönke Detlefsen, Maja Thiele, Alejandro Mayorca Guiliani, Ida Falk Villesen, Diana Julie Leeming, Morten Karsdal, Jonas Heilskov Graversen, Aleksander Krag   +16 more
doaj   +1 more source